ZNF585A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.831200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.499400E-01
Normal-vs-Stage2
3.731800E-01
Normal-vs-Stage3
3.212600E-01
Normal-vs-Stage4
7.974200E-01
Stage1-vs-Stage2
3.769800E-01
Stage1-vs-Stage3
4.800200E-02
Stage1-vs-Stage4
4.952400E-01
Stage2-vs-Stage3
1.443360E-01
Stage2-vs-Stage4
1.188220E-01
Stage3-vs-Stage4
2.982000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.995200E-01
Normal-vs-AfricanAmerican
6.541200E-01
Normal-vs-Asian
2.088600E-01
Caucasian-vs-AfricanAmerican
8.014400E-01
Caucasian-vs-Asian
1.717590E-01
AfricanAmerican-vs-Asian
2.796600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.216600E-01
Normal-vs-Female
3.641800E-01
Male-vs-Female
7.823800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.246000E-01
Normal-vs-Age(41-60Yrs)
5.313200E-01
Normal-vs-Age(61-80Yrs)
3.672800E-01
Normal-vs-Age(81-100Yrs)
4.756800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.082200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.821200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.939800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.398000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.133200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.984000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.529430E-01
Normal-vs-Daily Drinker
4.586000E-01
Normal-vs-Weekly Drinker
2.274200E-01
Normal-vs-Occasional Drinker
7.986600E-01
Normal-vs-Social Drinker
8.089000E-01
Non Drinker-vs-Daily Drinker
8.678800E-01
Non Drinker-vs-Weekly Drinker
8.351400E-01
Non Drinker-vs-Occasional Drinker
1.986170E-02
Non Drinker-vs-Social Drinker
1.672610E-01
Daily Drinker-vs-Weekly Drinker
7.132600E-01
Daily Drinker-vs-Occasional Drinker
1.337850E-02
Daily Drinker-vs-Social Drinker
1.415000E-01
Weekly Drinker-vs-Occasional Drinker
7.449800E-02
Weekly Drinker-vs-Social Drinker
2.347000E-01
Occasional Drinker-vs-Social Drinker
8.870600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.842570E-01
Normal-vs-Grade 2
6.710000E-02
Normal-vs-Grade 3
6.457600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.518800E-01
Grade 1-vs-Grade 3
2.924000E-01
Grade 1-vs-Grade 4
1.842570E-01
Grade 2-vs-Grade 3
4.228000E-01
Grade 2-vs-Grade 4
6.710000E-02
Grade 3-vs-Grade 4
6.457600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.778400E-01
Normal-vs-NonDiabetic
2.243000E-01
Diabetic-vs-NonDiabetic
6.366800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.335800E-01
Normal-vs-NoPancreatitis
3.106800E-01
Pancreatitis-vs-NoPancreatitis
5.995500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.783000E-01
Normal-vs-N1
3.606800E-01
N0-vs-N1
8.957200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.518000E-01
Normal-vs-TP53-NonMutant
5.340400E-01
TP53-Mutant-vs-TP53-NonMutant
1.111170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
